This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Resumen de acción CFMS
Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
+ 1 riesgos adicionales
Competidores de Conformis, Inc.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$2.26 |
| 52 Week High | US$7.25 |
| 52 Week Low | US$1.05 |
| Beta | 1.39 |
| 1 Month Change | 0.44% |
| 3 Month Change | 96.52% |
| 1 Year Change | -65.23% |
| 3 Year Change | -87.44% |
| 5 Year Change | -91.93% |
| Change since IPO | -99.53% |
Noticias y actualizaciones recientes
Recent updates
Conformis stock jumps 17% aftermarket on FDA 510(k) clearance for Actera hip system
Sep 13Conformis signs agreement with Vizient for personalized orthopedic implants
Aug 01Investors Will Want Conformis' (NASDAQ:CFMS) Growth In ROCE To Persist
Jan 11
We Think Conformis (NASDAQ:CFMS) Can Stay On Top Of Its Debt
Dec 21What Does Conformis, Inc.'s (NASDAQ:CFMS) Share Price Indicate?
Nov 11Is Conformis (NASDAQ:CFMS) A Risky Investment?
Sep 16Conformis: Emerging Surgical Implant Developer
Sep 04Shareholders Shouldn’t Be Too Comfortable With Conformis' (NASDAQ:CFMS) Strong Earnings
Aug 11Party Time: Brokers Just Made Major Increases To Their Conformis, Inc. (NASDAQ:CFMS) Earnings Forecasts
Aug 10Increases to Conformis, Inc.'s (NASDAQ:CFMS) CEO Compensation Might Cool off for now
May 18Analysts Just Shipped An Incredible Upgrade To Their Conformis, Inc. (NASDAQ:CFMS) Estimates
May 11Conformis wins FDA clearance for Identity Imprint Knee Replacement System
May 10Is Conformis (NASDAQ:CFMS) Using Debt Sensibly?
May 08ConforMIS EPS misses by $0.02, beats on revenue
May 05Is Conformis (NASDAQ:CFMS) Using Too Much Debt?
Jan 16Rentabilidad de los accionistas
| CFMS | US Medical Equipment | Mercado US | |
|---|---|---|---|
| 7D | 0% | 0.5% | -0.6% |
| 1Y | -65.2% | 3.0% | 21.7% |
Rentabilidad vs. Industria: CFMS underperformed the US Medical Equipment industry which returned 3.9% over the past year.
Rentabilidad vs. Mercado: CFMS underperformed the US Market which returned 11.1% over the past year.
Volatilidad de los precios
| CFMS volatility | |
|---|---|
| CFMS Average Weekly Movement | 25.0% |
| Medical Equipment Industry Average Movement | 7.8% |
| Market Average Movement | 5.8% |
| 10% most volatile stocks in US Market | 15.6% |
| 10% least volatile stocks in US Market | 2.9% |
Precio estable de las acciones: CFMS's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: CFMS's weekly volatility has increased from 20% to 25% over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2004 | 295 | Mark Augusti | www.conformis.com |
Resumen de fundamentos de Conformis, Inc.
| Estadísticas fundamentales de CFMS | |
|---|---|
| Capitalización bursátil | US$17.80m |
| Beneficios(TTM) | -US$41.50m |
| Ingresos (TTM) | US$57.06m |
0.3x
Ratio precio-ventas (PS)-0.4x
Ratio precio-beneficio (PE)¿Está CFMS sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de CFMS | |
|---|---|
| Ingresos | US$57.06m |
| Coste de los ingresos | US$38.12m |
| Beneficio bruto | US$18.95m |
| Otros gastos | US$60.45m |
| Beneficios | -US$41.50m |
Últimos beneficios comunicados
Jun 30, 2023
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -5.27 |
| Margen bruto | 33.21% |
| Margen de beneficio neto | -72.73% |
| Ratio deuda/patrimonio | 64.4% |
¿Cómo se ha desempeñado CFMS a largo plazo?
Ver rendimiento histórico y comparativa